Apellis Pharmaceuticals Inc (APLS)
58.74
+0.27
(+0.46%)
USD |
NASDAQ |
Mar 28, 16:00
58.75
+0.01
(+0.02%)
After-Hours: 19:59
Apellis Pharmaceuticals Total Assets (Quarterly): 788.73M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 788.73M |
September 30, 2023 | 818.22M |
June 30, 2023 | 915.58M |
March 31, 2023 | 978.87M |
December 31, 2022 | 760.22M |
September 30, 2022 | 872.89M |
June 30, 2022 | 1.002B |
March 31, 2022 | 1.146B |
December 31, 2021 | 881.76M |
September 30, 2021 | 525.69M |
June 30, 2021 | 699.91M |
March 31, 2021 | 810.13M |
December 31, 2020 | 960.57M |
September 30, 2020 | 768.33M |
June 30, 2020 | 870.11M |
March 31, 2020 | 688.94M |
Date | Value |
---|---|
December 31, 2019 | 389.24M |
September 30, 2019 | 466.36M |
June 30, 2019 | 316.70M |
March 31, 2019 | 318.35M |
December 31, 2018 | 203.53M |
September 30, 2018 | 239.15M |
June 30, 2018 | 266.82M |
March 31, 2018 | 163.20M |
December 31, 2017 | 182.13M |
September 30, 2017 | 19.14M |
June 30, 2017 | 56.69M |
December 31, 2016 | 27.43M |
December 31, 2015 | 38.18M |
September 30, 2015 | 13.74M |
June 30, 2015 | 16.82M |
December 31, 2014 | 14.31M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
316.70M
Minimum
Jun 2019
1.146B
Maximum
Mar 2022
748.95M
Average
799.43M
Median
Total Assets (Quarterly) Benchmarks
Blueprint Medicines Corp | 1.049B |
Alnylam Pharmaceuticals Inc | 3.830B |
Ionis Pharmaceuticals Inc | 2.990B |
Madrigal Pharmaceuticals Inc | 640.55M |
Sarepta Therapeutics Inc | 3.265B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 594.21M |
Shareholders Equity (Quarterly) | 194.52M |
Debt to Equity Ratio | 0.4783 |
Current Ratio | 3.095 |
Net Debt Paydown Yield | -0.00% |